IPO Date | August 8, 2025 to August 12, 2025 |
Listing Date | August 18, 2025 |
Face Value | ₹ 10 / Share |
Price Band | ₹ 135 to ₹ 142 / Share |
Lot Size | 1000 Shares |
Total Issue Size | 48,92,000 shares (Aggregating up to ₹69.47 Cr) |
Fresh Issue | 34,40,000 shares (Aggregating up to ₹48.85 Cr) |
Offer for Sale | |
Employee Discount | |
Issue Type | Bookbuilding IPO |
Listing At | BSE SME |
Share holding pre issue | 1,35,00,000 shares |
Share holding post issue | 1,74,20,000 shares |
Market Maker portion |
Star Imaging and Path Lab Limited IPO opens on August 8, 2025, and closes on August 12, 2025.
IPO Open Date | August 8, 2025 |
IPO Close Date | August 12, 2025 |
Basis of Allotment | August 13, 2025 |
Initiation of Refunds | August 14, 2025 |
Credit of Shares to Demat | August 14, 2025 |
Listing Date | August 18, 2025 |
Cut-off time for UPI mandate confirmation | August 12, 2025 |
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 2 | 2,000 | Rs.284,000 |
Retail (Max) | 2 | 2,000 | Rs.284,000 |
S-HNI (Min) | 3 | 3,000 | Rs.426,000 |
S-HNI (Max) | 7 | 7,000 | Rs.994,000 |
B-HNI (Min) | 8 | 8,000 | Rs.1,136,000 |
HNI (Min) |
Share Holding Pre Issue | 100% |
Share Holding Post Issue | 71.92% |
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
Anchor Investor Shares Offered | |
|
Market Maker Shares Offered | |
|
Other Shares Offered | |
|
QIB Shares Offered | Not more than 50% |
|
NII (HNI) Shares Offered | Not less than 15% |
|
bNII > ₹10L | |
|
sNII < ₹10L | |
|
Retail Shares Offered | Not less than 35% |
|
Employee Shares Offered | |
|
Total Shares Offered | |
Bid Date | |
Shares Offered | |
Anchor Portion Size (In Cr.) | |
Anchor lock-in period end date for 50% shares (30 Days) | |
Anchor lock-in period end date for remaining shares (90 Days) |
Founded in 2004, Star Imaging and Path Lab Limited is a medical company offering diagnostic services for a vast array of medical tests. The firm specializes in imaging diagnostics like X-rays, ultrasounds, CT scans, MRIs, and lab tests like blood tests, urine tests, and other specialized diagnostics. With state-of-the-art technology and skilled medical professionals, the company looks forward to providing timely and accurate reports to patients, assisting doctors in effective treatment and diagnosis.
The company has a strong presence in various regions, providing services to healthcare institutions and individuals.
Services:
Radiology: Digital X-ray, Mammography, CT scans, 4D & 5D ultrasound services.
Pathology: Haematology, Microbiology, PCR (polymerase chain reaction), Histopathology
Diagnotics: Routine Testing, Special Testing
As of 30th September 2024, the company has a total of 209 full time employees consisting of executive directors.
Competitive Strengths:
Proper Sample Collection and Processing Procedures
Specialized Expertise
Accurate Diagnosis
The market capitalization of Star Imaging IPO is ₹247.36 Cr.
KPI | Values |
---|---|
ROE | 40.65% |
ROCE | 29.92% |
Debt/Equity | 0.69 |
RoNW | 40.65% |
P/BV | 4.07 |
PAT Margin (%) | 19.10% |
Pre IPO | Post IPO | |
---|---|---|
EPS (Rs) | 11.82 | 9.16 |
P/E (x) | 12.01 | 15.5 |
Star Imaging & Path Lab Ltd. 4B/4, Tilak Nagar, Near Sant Pura, Tilak Nagar West Delhi, New Delhi, New Delhi, 110018 Phone: +91 9990019189 Email: [email protected] Website: https://www.starimaging.in/ |
Kfin Technologies Limited Phone: 04067162222, 04079611000 Email: [email protected] |
Lamfindia specializes in offering innovative financial solutions, including stock broker services, mutual fund investments, and IPO guidance.